Terms: = Lymphoma AND HIST1H4I, MGC24116, 8294, P62805
5 results:
1. High incidence of intact or fragmented immunoglobulin in urine of patients with multiple myeloma.
Kraj M; Kruk B; Lech-Marańda E; Warzocha K; Prochorec-Sobieszek M
Leuk Lymphoma; 2015; 56(12):3348-56. PubMed ID: 25860239
[TBL] [Abstract] [Full Text] [Related]
2. Phase II study of interim PET-CT-guided response-adapted therapy in advanced Hodgkin's lymphoma.
Ganesan P; Rajendranath R; Kannan K; Radhakrishnan V; Ganesan TS; Udupa K; Lakshmipathy KM; Mahajan V; Sundersingh S; Rajaraman S; Krishnakumar R; Sagar TG
Ann Oncol; 2015 Jun; 26(6):1170-1174. PubMed ID: 25701453
[TBL] [Abstract] [Full Text] [Related]
3. Rituximab-based chemoimmunotherapy prolongs survival of patients with chronic lymphocytic leukemia independently of the time of administration.
Delgado J; Ghita G; Baumann T; Santacruz R; Dlouhy I; Aymerich M; Rozman M; Creus N; Pereira A; Montserrat E
Clin Lymphoma Myeloma Leuk; 2014 Feb; 14(1):73-9. PubMed ID: 24126217
[TBL] [Abstract] [Full Text] [Related]
4. Near-tetraploidy in childhood B-cell precursor acute lymphoblastic leukemia is a highly specific feature of ETV6/RUNX1-positive leukemic cases.
Attarbaschi A; Mann G; König M; Steiner M; Dworzak MN; Gadner H; Haas OA;
Genes Chromosomes Cancer; 2006 Jun; 45(6):608-11. PubMed ID: 16552772
[TBL] [Abstract] [Full Text] [Related]
5. Childhood acute lymphoblastic leukemia immunophenotypes and their prognostic significance: experience of the IGCI-study in 389 children. International Society for Chemo-immunotherapy (IGCI-Vienna) Cooperative Group.
Holowiecki J; Koehler M; Zintl Z; Kardos G; Lutz D; Krzemien S; Rewesz T; Brugiatelli M; Callea V; Kachel L
Leuk Lymphoma; 1992 Jun; 7(3):225-34. PubMed ID: 1477650
[TBL] [Abstract] [Full Text] [Related]
